Natalizumab binding to peripheral blood mononuclear cells analysed by flow cytometry can be used for monitoring treatment response in patients with multiple sclerosis

Research output: Contribution to journalAbstract (Journal)peer-review

Original languageEnglish
Pages (from-to)13-14
JournalJOURNAL OF NEUROLOGY
Volume258
Publication statusPublished - 2011
Event21st Meeting of the European-Neurological-Society - Lisbon, PORTUGAL
Duration: 28 Jan 201131 Jan 2011

Cite this